The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group.

Guilhot, F; Guerci, A; Fiere, D; Harousseau, J L; Maloisel, F; Bouabdallah, R; Guyotat, D; Rochant, H; Najman, A; Nicolini, F; Colombat, P; Abgrall, J F; Ifrah, N; Brière, J; Bauters, F; Navarro, M; Morice, P; Bordessoule, D; Vilque, J P; Desablens, B; Tertian, G; Blanc, M; Chastang, C; Tanzer, J

Guilhot, F; Guerci, A; Fiere, D; Harousseau, J L; Maloisel, F; Bouabdallah, R; Guyotat, D; Rochant, H; Najman, A; Nicolini, F; Colombat, P; Abgrall, J F; Ifrah, N; Brière, J; Bauters, F; Navarro, M; Morice, P; Bordessoule, D; Vilque, J P; Desablens, B; Tertian, G; Blanc, M; Chastang, C; Tanzer, J.

Affiliation

Guilhot F; Département d'Hématologie et Oncologie Médicale, CHU La Milétrie, Poitiers, France.

Bone Marrow Transplant ; 17 Suppl 3: S29-31, 1996 May.

Article in En | MEDLINE | ID: mdl-8769697

Subject(s)

Antineoplastic Agents/administration & dosage; Cytarabine/administration & dosage; Interferon-alpha/administration & dosage; Leukemia, Myeloid, Chronic-Phase/drug therapy; Leukemia, Myeloid, Chronic-Phase/therapy; Randomized Controlled Trials as Topic/methods; Adult; Aged; Antineoplastic Agents/adverse effects; Combined Modality Therapy; Drug Tolerance; France; Humans; Hydroxyurea/administration & dosage; Interferon alpha-2; Interferon-alpha/adverse effects; Middle Aged; Recombinant Proteins

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Leukemia, Myeloid, Chronic-Phase / Randomized Controlled Trials as Topic / Interferon-alpha / Cytarabine / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 1996 Type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links